A first-of-its-kind drug targeting a fused gene found in many types of cancer was effective in 93 percent of pediatric patients tested, researchers at UT Southwestern’s Simmons Cancer Center announced. The research was published in March 2018 in The Lancet Oncology. A release from the medical center explains that most cancer drugs are targeted to… Continue reading Pediatric Cancer Drug Shows 93 Percent Response Rate